Product Information
QC PAIN RLF PM 25-500 MG CAPLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0439 per EA under NDC 83324008501. Its NADAC has been published 87 times since Feb 5, 2025.
Strength
500; 25 mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324008501
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
4/29/2024
Pharmacological Classes
Price Statistics
The NADAC for QC PAIN RLF PM 25-500 MG CAPLET has been published 87 times since Feb 5, 2025, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0439 per EA |
|---|---|
| All-time high | $0.0486 (Feb 12, 2025) |
| All-time low | $0.0436 (Feb 19, 2025) |
| 52-week high | $0.0470 |
| 52-week low | $0.0439 |
| Median price | $0.0456 |
| Average price | $0.0459 |
| Largest weekly change | -10.4% (Feb 19, 2025) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen and Diphenhydramine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC PAIN RLF PM 25-500 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for QC PAIN RLF PM 25-500 MG CAPLET, manufactured by Chain Drug Marketing Association, is $0.0439 per EA (NDC 83324008501), effective Sep 30, 2026.
How has the price of QC PAIN RLF PM 25-500 MG CAPLET changed over time?
Over the history we have for it, the NADAC for QC PAIN RLF PM 25-500 MG CAPLET has declined 9.7%. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC PAIN RLF PM 25-500 MG CAPLET?
Since Feb 5, 2025, the NADAC for QC PAIN RLF PM 25-500 MG CAPLET has ranged from a low of $0.0436 (Feb 19, 2025) to a high of $0.0486 (Feb 12, 2025), with a median of $0.0456 per EA.
Are there cheaper alternatives to QC PAIN RLF PM 25-500 MG CAPLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as QC PAIN RLF PM 25-500 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures QC PAIN RLF PM 25-500 MG CAPLET?
QC PAIN RLF PM 25-500 MG CAPLET (NDC 83324008501) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.